Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency

被引:19
|
作者
Yang, Xiao-Wen [1 ]
He, Wen-Bin [1 ,2 ]
Gong, Fei [1 ,2 ]
Li, Wen [1 ,2 ]
Li, Xiu-Rong [1 ,2 ]
Zhong, Chang-Gao [1 ,2 ]
Lu, Guang-Xiu [1 ,2 ]
Lin, Ge [1 ,2 ]
Du, Juan [1 ,2 ]
Tan, Yue-Qiu [1 ,2 ]
机构
[1] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China
[2] Reprod & Genet Hosp Cit Xiangya, Changsha, Hunan, Peoples R China
来源
关键词
blepharophimosis-ptosis-epicanthus inversus syndrome; FOXL2; novel mutation; premature ovarian insufficiency; TRANSCRIPTION FACTOR FOXL2; BPES; STRESS; MUTANT; MOUSE; GENE; LEAD;
D O I
10.1002/mgg3.366
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundBlepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is a malformation of the eyelids. Forkhead BoxL2 (FOXL2) is the only gene known to be associated with BPES. MethodsWe identified two Han Chinese BPES families with premature ovarian insufficiency (POI). Sanger sequencing and invitro functional analysis were performed to identify the genetic cause. ResultsSanger sequencing identified two novel mutations (c.462_468del, c.988_989insG) in FOXL2, one in each family. The invitro functional analysis confirmed that both novel mutations were associated with impaired transactivation of downstream genes. Specifically, the single-base insertion, c.988_989insG, led to subcellular mislocalization and aggregation of the encoded protein, which validated the hypothesis that the two novel FOXL2 mutations are deleterious and associated with POI in the two BPES families. ConclusionThe novel mutations identified in the present study will enhance the present knowledge of the mutation spectrum of FOXL2. The invitro experiments provide further insights into the molecular mechanism by which the two new variants mediate disease pathogenesis and may contribute to elucidating the genotype-phenotype correlation between the two novel FOXL2 mutations and POI.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [41] FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES);: Challenges for genetic counseling in female patients
    Fokstuen, S
    Antonarakis, SE
    Blouin, JL
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 117A (02) : 143 - 146
  • [42] The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
    Laura Crisponi
    Manila Deiana
    Angela Loi
    Francesca Chiappe
    Manuela Uda
    Patrizia Amati
    Luigi Bisceglia
    Leopoldo Zelante
    Ramaiah Nagaraja
    Susanna Porcu
    M. Serafina Ristaldi
    Rosalia Marzella
    Mariano Rocchi
    Marc Nicolino
    Anne Lienhardt-Roussie
    Annie Nivelon
    Alain Verloes
    David Schlessinger
    Paolo Gasparini
    Dominique Bonneau
    Antonio Cao
    Giuseppe Pilia
    Nature Genetics, 2001, 27 : 159 - 166
  • [43] Blepharophimosis-ptosis-epicanthus inversus syndrome caused by a 54-kb microdeletion in a FOXL2 cis-regulatory element
    Bouman, Arjan
    van Haelst, Mieke
    van Spaendonk, Rosalina
    CLINICAL DYSMORPHOLOGY, 2018, 27 (02) : 58 - 62
  • [44] Differential Apoptotic and Proliferative Activities of Wild-type FOXL2 and Blepharophimosis-ptosis-epicanthus Inversus Syndrome (BPES)-associated Mutant FOXL2 Proteins
    Kim, Jae-Hong
    Bae, Jeehyeon
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2014, 60 (01): : 14 - 20
  • [45] Identification and functional analyses of a novel FOXL2 pathogenic variant causing blepharophimosis, ptosis, and epicanthus inversus syndrome
    Yan, Yu-Cheng
    Zhou, Lu
    Fan, Jin-Cai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2023, 16 (05) : 680 - 686
  • [46] The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
    Crisponi, L
    Deiana, M
    Loi, A
    Chiappe, F
    Uda, M
    Amati, P
    Bisceglia, L
    Zelante, L
    Nagaraja, R
    Porcu, S
    Ristaldi, MS
    Marzella, R
    Rocchi, M
    Nicolino, M
    Lienhardt-Roussie, A
    Nivelon, A
    Verloes, A
    Schlessinger, D
    Gasparini, P
    Bonneau, D
    Cao, A
    Pilia, G
    NATURE GENETICS, 2001, 27 (02) : 159 - 166
  • [47] Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome in A Pakistani Pedigree
    Chaudhry, Tanveer Anjum
    Khalid, Mirza Umair
    Saleem, Taimur
    Ahmad, Khabir
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (04): : 285 - 286
  • [48] Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus
    Chacon-Camacho, Oscar F.
    Salgado-Medina, Acatzin
    Alcaraz-Lares, Nayeli
    Lopez-Moreno, Daniel
    Barragan-Arevalo, Tania
    Nava-Castaneda, Angel
    Rodriguez-Uribe, Genaro
    Lieberman, Esther
    Rodriguez-Cabrera, Lourdes
    Gonzalez-Del Angel, Ariadna
    Maria Borbolla, Ana
    Fernandez-Hernandez, Liliana
    Graue-Hernandez, Enrique O.
    Carlos Zenteno, Juan
    GENE, 2019, 706 : 62 - 68
  • [49] A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I
    Martinez-Aguayo, Alejandro
    Poggi, Helena
    Cattani, Andreina
    Molina, Marcela
    Romeo, Eliana
    Lagos, Marcela
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (1-2): : 181 - 184
  • [50] Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2
    Bell, R
    Murday, VA
    Patton, MA
    Jeffery, S
    GENETIC TESTING, 2001, 5 (04): : 335 - 338